|
1
|
Ferlay J, Colombet M, Soerjomataram I,
Dyba T, Randi G, Bettio M, Gavin A, Visser O and Bray F: Cancer
incidence and mortality patterns in Europe: Estimates for 40
countries and 25 major cancers in 2018. Eur J Cancer. 103:356–387.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li J, Chen Z, Su K and Zeng J:
Clinicopathological classification and traditional prognostic
indicators of breast cancer. Int J Clin Exp Pathol. 8:8500–8505.
2015.PubMed/NCBI
|
|
4
|
Nagini S: Breast cancer: Current molecular
therapeutic targets and new players. Anticancer Agents Med Chem.
17:152–163. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chiappa C, Rovera F, Rausei S, Del Ferraro
S, Fachinetti A, Lavazza M, Marchionini V, Arlant V, Tanda ML,
Piantanida E, et al: Breast cancer and thyroid diseases: Analysis
of 867 consecutive cases. J Endocrinol Invest. 40:179–184. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hammerl D, Smid M, Timmermans AM, Sleijfer
S, Martens JWM and Debets R: Breast cancer genomics and
immuno-oncological markers to guide immune therapies. Semin Cancer
Biol. 52:178–188. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bates JP, Derakhshandeh R, Jones L and
Webb TJ: Mechanisms of immune evasion in breast cancer. BMC Cancer.
18:5562018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pérez-González O, Cuéllar-Guzmán LF, Soliz
J and Cata JP: Impact of regional anesthesia on recurrence,
metastasis, and immune response in breast cancer surgery: A
systematic review of the literature. Reg Anesth Pain Med.
42:751–756. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Z, Zhang A, Zheng L, Johnathan AF,
Zhang J and Zhang G: The biological significance and regulatory
mechanism of c-Myc Binding Protein 1 (MBP-1). Int J Mol Sci.
19:38682018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hsu KW, Hsieh RH, Wu CW, Chi CW, Lee YH,
Kuo ML, Wu KJ and Yeh TS: MBP-1 suppresses growth and metastasis of
gastric cancer cells through COX-2. Mol Biol Cell. 20:5127–37.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cancemi P, Buttacavoli M, Roz E and Feo S:
Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1
(MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the
Nature and Aggressiveness of Breast Tumors. Int J Mol Sci.
20:39522019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fan X, Solomon H, Schwarz K, Kew MC, Ray
RB and Di Bisceglie AM: Expression of c-myc promoter binding
protein (MBP-1), a novel eukaryotic repressor gene, in cirrhosis
and human hepatocellular carcinoma. Dig Dis Sci. 46:563–566. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kanda T, Raychoudhuri A, Steele R, Sagartz
JE, West C and Ray RB: MBP-1 inhibits breast cancer growth and
metastasis in immunocompetent mice. Cancer Res. 69:9354–9359. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ray RB, Steele R, Seftor E and Hendrix M:
Human breast carcinoma cells transfected with the gene encoding a
c-myc promoter-binding protein (MBP-1) inhibits tumors in nude
mice. Cancer Res. 55:3747–3751. 1995.PubMed/NCBI
|
|
15
|
Lo Presti M, Ferro A, Contino F,
Mazzarella C, Sbacchi S, Roz E, Lupo C, Perconti G, Giallongo A,
Migliorini P, et al: Myc promoter-binding protein-1 (MBP-1) is a
novel potential prognostic marker in invasive ductal breast
carcinoma. PLoS One. 5:e129612010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ray RB and Steele R: Separate domains of
MBP-1 involved in c-myc promoter binding and growth suppressive
activity. Gene. 186:175–80. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ray R, Sheikh S, Fontana J and Miller D:
Human breast-carcinoma cells show correlation in expression of
C-myc oncogene and the C-myc binding-protein (mbp-1). Int J Oncol.
5:1433–1436. 1994.PubMed/NCBI
|
|
18
|
Zhuang Y, Li X, Zhan P, Pi G and Wen G:
MMP11 promotes the proliferation and progression of breast cancer
through stabilizing Smad2 protein. Oncol Rep. 45:162021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang P, Yan R, Zhang X, Wang L, Ke X and
Qu Y: Activating Wnt/β-catenin signaling pathway for disease
therapy: Challenges and opportunities. Pharmacol Ther. 196:79–90.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Macklin PS, McAuliffe J, Pugh CW and
Yamamoto A: Hypoxia and HIF pathway in cancer and the placenta.
Placenta. 56:8–13. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Katoh M: Multi-layered prevention and
treatment of chronic inflammation, organ fibrosis and cancer
associated with canonical WNT/β-catenin signaling activation
(Review). Int J Mol Med. 42:713–725. 2018.PubMed/NCBI
|
|
23
|
Krishnamurthy N and Kurzrock R: Targeting
the Wnt/beta-catenin pathway in cancer: Update on effectors and
inhibitors. Cancer Treat Rev. 62:50–60. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Steele R, Mott JL and Ray RB: MBP-1
upregulates miR-29b that represses Mcl-1, collagens, and
matrix-metalloproteinase-2 in prostate cancer cells. Genes Cancer.
1:381–387. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hsu KW, Wang AM, Ping YH, Huang KH, Huang
TT, Lee HC, Lo SS, Chi CW and Yeh TS: Downregulation of tumor
suppressor MBP-1 by microRNA-363 in gastric carcinogenesis.
Carcinogenesis. 35:208–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jing X, Yang F, Shao C, Wei K, Xie M, Shen
H and Shu Y: Role of hypoxia in cancer therapy by regulating the
tumor microenvironment. Mol Cancer. 18:1572019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tan M, Gu Q, He H, Pamarthy D, Semenza GL
and Sun Y: SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1
alpha ubiquitination and degradation. Oncogene. 27:1404–1411. 2008.
View Article : Google Scholar : PubMed/NCBI
|
